Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02987244
What this trial is testing

Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

Who this might be right for
T Cell Non-Hodgkin's Lymphoma
Peking Union Medical College Hospital 100
Large-scale testing (Phase 3)UnknownNCT03391739
What this trial is testing

CART-19 Cells For R/R B-ALL

Who this might be right for
Relapsed/Refractory B-cell ALL
Fujian Medical University 20
Not applicableLooking for participantsNCT06450067
What this trial is testing

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 200
Not applicableNot Yet RecruitingNCT07463781
What this trial is testing

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell LymphomaPrimary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Study completedNCT03343665
What this trial is testing

Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)Study completedNCT01029730
What this trial is testing

Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma

Who this might be right for
Lymphoma
SCRI Development Innovations, LLC 55
Early research (Phase 1)Ended earlyNCT05096234
What this trial is testing

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Stanford University 2
Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Early research (Phase 1)Study completedNCT00347971
What this trial is testing

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
ZymoGenetics 23
Not applicableLooking for participantsNCT06292741
What this trial is testing

Autonomic Involvement in Patient With Cognitive Decline

Who this might be right for
Dementia, MildDementia of Alzheimer Type
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Testing effectiveness (Phase 2)Study completedNCT00875056
What this trial is testing

Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Testing effectiveness (Phase 2)UnknownNCT05059912
What this trial is testing

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Who this might be right for
Refractory and Relapsed T Cell Lymphoma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT05064319
What this trial is testing

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Who this might be right for
Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar Type+5 more
Medical University of South Carolina 51
Early research (Phase 1)WithdrawnNCT05867030
What this trial is testing

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Innovent Biologics (Suzhou) Co. Ltd.
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Large-scale testing (Phase 3)Study completedNCT00052936
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Next Page